Mizuho Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $55

Benzinga Newsdesk www.benzinga.com Negative 94.4%

Neg 94.4% Neu 0% Pos 0%

Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the price target from $70 to $55.